This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

Andrew Harmon
Senior Consultant, Strategic Consulting at Latham Biopharm Group


Mr. Harmon is an experienced life sciences professional with specialization in finance and strategy and a technical background in molecular biology and biotechnology with a focus on drug development and the biomanufacturing process. As a Senior Consultant at LBG, he leads the day-to-day aspects of strategic finance projects, conducts financial modeling and analysis, supports the technical review of new life sciences products, and manages non-dilutive and commercially funded programs across the product lifecycle for innovative products, including manufacturing platforms, biologics, small molecules, and drug delivery devices.

Agenda Sessions

  • Panel: BioProcess Insider State of the Industry Q3 2023